| (USD) | Jun 2023 | Q/Q |
|---|---|---|
| Revenue | 14.1MM | -24% |
| Gross Profit | 6MM | -55% |
| Cost Of Revenue | 8MM | +58% |
| Operating Income | -47.2MM | - |
| Operating Expenses | 53.2MM | +47% |
| Net Income | -50.2MM | - |
| R&D | 9.3MM | +11% |
| G&A | - | - |
| Marketing | - | - |
| Interest Expense | 1.6MM | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation at the American Association of Cancer Research (AACR) Annual Meeting 2023 being held from April 14-19 at the Orange County Convention Center in Orlando, Fla. AACR brings together scientists, clinicians, other health care professionals, survivors, patients, and advocates to share the latest advances in cancer science and medicine through this year's meeting theme of "Advancing the Frontiers of Can
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health. The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol "CELL" at market open tomorrow.
Berkeley Lights ( NASDAQ:BLI ) Full Year 2022 Results Key Financial Results Revenue: US$78.6m (down 8.0% from FY 2021...
Q4 2022 Berkeley Lights Inc Earnings Call
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
In this piece, we will take a look at the 15 worst stock picks of Cathie Wood in 2022. For her top five worst stock picks, head on over to 5 Worst Stock Picks of Cathie Wood in 2022. Cathie Wood is one of the more popular hedge fund investors when it comes to the […]
Berkeley Lights Inc (NASDAQ: BLI) announced preliminary FY22 revenue of $78-$78.5 million, compared to $85.4 million in 2021, missing the consensus of $85.36 million. The company said the results were lower-than-expected due to delays in several Beacon platform placements, which are now expected in 2023, and lower revenue from partnership and services contracts. During Q4 FY22, the company observed a tightening macroeconomic environment. Related: Berkeley Lights Scoops Up IsoPlexis, Creating A P
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended December 31, 2022. Total revenue for the full year 2022 is expected to be in the range of $78.0 million to $78.5 million, compared to $85.4 million in 2021.
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development (CLD). The Beacon Select builds upon the same cutting-edge technology offered by the original Beacon system launched in 2017 that currently has an installed base of more than 130 systems globally. The Beacon Select offers customers optofluidic and NanoPen® chamber technology and propriety CLD applications, but with th